Results 171 to 180 of about 117,912 (291)

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

New England Journal of Medicine, 2003
J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes, C. O'shaughnessy, R. Caputo, D. Kereiakes, David O. Williams, P. Teirstein, Judith Jaeger, R. Kuntz   +11 more
semanticscholar   +1 more source

The evaluation for Clinical usefulness and Safety of Sirolimus-eluting stent and Paclitaxel-Eluting Stents In Patients With Acute Myocardial Infarction [PDF]

, 2012
Gyesik Min, Man-Seok Han
openalex   +1 more source

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

New England Journal of Medicine, 2002
M. Morice, P. Serruys, J. Sousa, J. Fajadet, E.Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnár, R. Falotico   +11 more
semanticscholar   +1 more source

Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy

International Journal of Nanomedicine, 2012
Ha Na Woo1*, Hye Kyung Chung2*, Eun Jin Ju1, Joohee Jung1,3, Hye-Won Kang4, Sa-Won Lee4, Min-Hyo Seo4, Jin Seong Lee5, Jung Shin Lee1,6, Heon Joo Park7, Si Yeol Song1,8, Seong-Yun Jeong1, Eun Kyung Choi1,2,81Institute for Innovative Cancer Research ...
Woo HN, Chung HK, Ju EJ, Jung J, Kang HW, Lee SW, Seo MH, Lee JS, Lee JS, Park HJ, Song SY, Jeong SY, Choi EK   +12 more
doaj  

Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: Multicenter study in Japan [PDF]

, 2008
Daizaburo Yanagi, Kazuyuki Shirai, Yosuke Takamiya, Yusuke Fukuda, Takashi Kuwano, Amane Ike, Ken Mori, Kazumitsu Kubota, Atsushi Iwata, Kanta Fujimi, Akira Kawamura, Hiroaki Nishikawa, Nathan Miller, Bo Zhang, Yoshihiro Tsuchiya, Hidenori Urata, Keijiro Saku   +16 more
openalex   +1 more source

Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.

Journal of Vascular Surgery, 2020
Cristiana Freixo, Vítor Ferreira, Joana Martins, R. Almeida, D. Caldeira, M. Rosa, João Costa, J. Ferreira   +7 more
semanticscholar   +1 more source

Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results

Annals of the Child Neurology Society
Objective Tuberous sclerosis complex (TSC) results from overactivity of the mechanistic target of rapamycin (mTOR). Sirolimus and everolimus are mTOR inhibitors that treat most facets of TSC but are understudied in infants.
Jamie K. Capal, David M. Ritter, David Neal Franz, Molly Griffith, Kristn Currans, Bridget Kent, E. Martina Bebin, Hope Northrup, Mary Kay Koenig, Tomoyuki Mizuno, Alexander A. Vinks, Stephanie L. Galandi, Wujuan Zhang, Kenneth D.R. Setchell, Kelly M. Kremer, Carlos M. Prada, Hansel M. Greiner, Katherine Holland‐Bouley, Paul S. Horn, Darcy A. Krueger   +19 more
doaj   +1 more source

Coronary endothelial dysfunction following sirolimus-eluting stent placement: should we worry about it?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology. [PDF]

, 2005
Amir Lerman, Éric Eeckhout
openalex   +1 more source

Gender difference on 5-year outcomes of EXCEL biodegradable polymer-coated sirolimus-eluting stents implantation: results from the CREATE study [PDF]

, 2013
Yaling Han, L. Zhang, Bo Xu
openalex   +1 more source

HIPERTRIGLICERIDEMIA GRAVE EM PACIENTE COM DOENÇA DO ENXERTO CONTRA HOSPEDEIRO EM TRATAMENTO COM RUXOLITINIBE, SIROLIMUS E CORTICOIDE

, 2020
CL Voltarelli, M.D. Marquetti, BSL Wan-Dall, Caroline Sola, Samir Nabhan, Marcela M. Oliveira, D.C. Setubal, Marco A. Bitencourt, B.C. Tan, Vaneuza Araújo Moreira Funke   +9 more
openalex   +1 more source